Selecting a site will automatically redirect you to the site's homepage.
Immunotherapy has not worked well against fibrolamellar carcinoma, but a new study finds an existing FDA-approved drug may allow the treatment to fight the cancer as intended.
A nationwide campaign that resulted in hundreds of scientists publishing letters in their hometown newspapers about the value of federal research funding has received the Meeting the Moment for Public Health Award from the non-profit Research!America.
